Thomas B. Neff, Chief Executive Officer at FIBROGEN INC (FGEN), sold 39,136 shares at $54.60 ($2.1M) on 2019-04-03, disclosed to the SEC on 2019-04-05.
Seasonal sale ($2.1M) by Chief Executive Officer — this insider has traded FGEN in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.60 | 1,418 | $77K | 3.7% |
| 2 | $54.63 | 18,200 | $994K | 47.0% |
| 3 | $53.12 | 1,118 | $59K | 2.8% |
| 4 | $53.17 | 13,900 | $739K | 34.9% |
| 5 | $54.24 | 2,700 | $146K | 6.9% |
| 6 | $55.14 | 1,800 |
| $99K |
| 4.7% |
| Total | $54.06 avg | 39,136 | $2.1M | 100% |
| Filing → |
| FGEN | SELL | 2018-12-06 | $1.2M | — | Filing → |
| FGEN | SELL | 2018-11-21 | $1.5M | — | Filing → |
| FGEN | SELL | 2018-11-02 | $1.6M | — | Filing → |